Trial Outcomes & Findings for Behavior During Experimentally Induced Pain (NCT NCT01594528)

NCT ID: NCT01594528

Last Updated: 2019-03-22

Results Overview

number of corporal mobility, facial expression and sound indicators

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

49 participants

Primary outcome timeframe

during pain tests (average 1 hour)

Results posted on

2019-03-22

Participant Flow

Participant milestones

Participant milestones
Measure
Control
behavior during experimental pain tests for control subjects pain tests: pain induction with pressure application or ischemia on the arm
SChizophrenia
behavior during experimental pain tests for subjects with schizophrenia pain tests: pain induction with pressure application or ischemia on the arm
Major Depression
behavior during experimental pain tests for subjects with major depression pain tests: pain induction with pressure application or ischemia on the arm
Overall Study
STARTED
16
17
16
Overall Study
COMPLETED
16
17
16
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Behavior During Experimentally Induced Pain

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Major Depression
n=16 Participants
subjects with major depression
Schizophrenia
n=17 Participants
subjects with schizophrenia
Control
n=16 Participants
subjects without psychiatric disorders
Total
n=49 Participants
Total of all reporting groups
Age, Continuous
46 years
n=5 Participants
42 years
n=7 Participants
40 years
n=5 Participants
41 years
n=4 Participants
Sex: Female, Male
Female
13 Participants
n=5 Participants
3 Participants
n=7 Participants
6 Participants
n=5 Participants
22 Participants
n=4 Participants
Sex: Female, Male
Male
3 Participants
n=5 Participants
14 Participants
n=7 Participants
10 Participants
n=5 Participants
27 Participants
n=4 Participants
Region of Enrollment
France
16 Participants
n=5 Participants
17 Participants
n=7 Participants
16 Participants
n=5 Participants
49 Participants
n=4 Participants

PRIMARY outcome

Timeframe: during pain tests (average 1 hour)

number of corporal mobility, facial expression and sound indicators

Outcome measures

Outcome measures
Measure
Group of Subjects Presenting Schizophrenia SC
n=17 Participants
subjects with diagnosis of schizophrenia according to the DSM-IV-TR and experimentating pain tests: pain induction with pressure application or ischemia on the arm. and observation of the behavior as defined with facial, corporal and vocal indicators during experimental pain tests
Group of Subjects Presenting Major Depression MD
n=16 Participants
subjects presenting a diagnosis of major depression according to the DSM-IV-TR and experimentating pain tests: pain induction with pressure application or ischemia on the arm. and observation of the behavior as defined with facial, corporal and vocal indicators during experimental pain tests
Group of Subjects Without Psychiatric Troubles C
n=16 Participants
control subjects without any psychiatric disorder and experimentating the same pain tests as the other groups: pain induction with pressure application or ischemia on the arm. and observation of the behavior as defined with facial, corporal and vocal indicators during experimental pain tests
Indicators / Minute
vocal indicators
1.925 indicators/minute
Interval 0.0 to 2.4
0.23 indicators/minute
Interval 0.0 to 4.23
0.4 indicators/minute
Interval 0.0 to 1.15
Indicators / Minute
body indicators
0.45 indicators/minute
Interval 0.0 to 1.6
0.59 indicators/minute
Interval 0.0 to 2.1
0.55 indicators/minute
Interval 0.0 to 2.7
Indicators / Minute
facial indicators
0.25 indicators/minute
Interval 0.0 to 1.5
0.4975 indicators/minute
Interval 0.1 to 3.95
0.45 indicators/minute
Interval 0.1 to 4.25

Adverse Events

Diagnosis

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr Murielle Girard

Centre Hospitalier Esquirol

Phone: 0033555431028

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place